Published in Blood Weekly, April 18th, 2002
"Patented photosis technology being developed by Oncosis delivers a substantially improved purging procedure, eliminating tumor cells and resulting in a disease-free product. Using photosis in recent laboratory trials, we have established the degree of tumor contamination down to the level of one detectable cell in an entire transplant. ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.